Companies
Pharmadule Morimatsu
Chinese firms, including local subsidiaries of Pharmadule Morimatsu, tightly integrate TEA with rapid modular facility engineering to compress the time from financial modeling to operational plant.
- Country
- China
Commercial
Modular Facilities
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| consulting-strategy | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaema
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Production site | Suzhou, China (70,000 sqm workshop area) | pharmadule.com |
| Production site | Nantong, China (160,000 sqm workshop area) | pharmadule.com |
| Production site | Shanghai, China | pharmadule.com |
| Capacity | more than 20,000L (for Zencore Biologics turnkey facility) | cleanroomtechnology.com |
| Certification | WHO compliant design and fabrication | morimatsu-lifesciences.com · pharmadule.com |
| Certification | cGMP compliant design | pharmadule.com |
Independent sources: cleanroomtechnology.com · morimatsu-lifesciences.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Techno-economic analysis (TEA) for bioprocesses | consulting-strategy | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.